Study finds microbiota transfer therapy provides long-term improvement in gut health in children with autism
A new study by ASU researchers and some of their colleagues is finding a potentially more promising way to improve communication between the human gut and the brain, which could provide an effective treatment for symptoms of autism spectrum disorder. One in 44 children in the U.S. are adfected by the disorder. Fulton Schools professors Rosa Krajmalnik-Brown and James Adams are among collaborators on the research. Krajmalnik-Brown directs ASU’s Biodesign Center for Health Through Microbiomes. Adams directs ASU’s Autism/Asperger’s Research Program. They are working on the project’s second phase, seeking to verify whether the findings that a microbiota transfer procedure involving the transfer of gut microbiota from healthy donors to autism spectrum disorder patients will prove correct in follow-up tests.